Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy (NCT07410611) | Hebei Medical University Fourth Hospital | 2026-02-10 |
Track Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination automatically
Every clearance here is in the API, with alerts when new ones post.